1,972
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Cervical lymph node metastasis of bladder cancer: a case report and review of literature

, , , , , , & show all
Article: 2205935 | Received 01 Nov 2022, Accepted 18 Apr 2023, Published online: 10 May 2023

References

  • Soave A, Kluwe L, Yu H, et al. Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy. Sci Rep. 2020;10(1):21562–21562.
  • Kafkasli A, Yazici O, Can U, et al. Testosterone status is not associated with bladder cancer parameters in adult male patients: results of a prospective controlled study. Aging Male. 2021;24(1):101–105.
  • Wang P, Zang S, Li G, et al. The role of surgery on the primary tumor site in bladder cancer with distant metastasis: significance of histology type and metastatic pattern. Cancer Med. 2020;9(24):9293–9302. [
  • Roth B, Wissmeyer MP, Zehnder P, et al. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol. 2010;57(2):205–211.
  • Hessan H, Strauss M, Sharkey FE. Urogenital tract carcinoma metastatic to the head and neck. Laryngoscope. 1986;96:1352–1356.
  • Wallmeroth A, Wagner U, Moch H, et al. Patterns of metastasis in muscle invasive bladder cancer (pT2-4): an autopsy study on 367 patients. Urol Int. 1999;62(2):69–75.
  • Tunio M, Rafi M, Hashmi A, et al. Choroidal metastasis from primary transitional cell carcinoma of urinary bladder: a case report and review of literature. Rawal Med J. 2011;36:69–70.
  • Ando T, Katagiri A, Nakayama R, et al. Hypercalcemia associated with lymph node metastasis following radical cystectomy for bladder cancer. IJU Case Rep. 2018;1(1):25–28.
  • Sengelov L, Kamby C, von der MH. Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma. J Urol. 1996;155(1):111–114.
  • Stein JP, Cai J, Groshen S, et al. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol. 2003;170(1):35–41.
  • Kancharla VP, Gulmi FA, Agheli A, et al. Transitional cell carcinoma of the bladder manifestating as malignant lymphoma with generalized lymphadenopathy. Case Rep Oncol. 2010;3(2):125–130.
  • Tunio MA, Asiri M, Bayoumi Y, et al. Cervical lymph node metastasis from transitional cell carcinoma of urinary bladder: case report and review of literature. JST. 2012;2(3):59.
  • Xie H, Xu Y-M. A case of postoperative axillary lymph node metastasis from bladder cancer. J Clin Urol. 2002;17(12):645.
  • Kim A, Kim MS, Ahn JH, et al. Clinical significance of 5-α reductase inhibitor and androgen deprivation therapy in bladder cancer incidence, recurrence, and survival: a meta-analysis and systemic review. Aging Male. 2020;23(5):971–978.
  • Zhou L, Liang X, Zhang K. Assessment of the clinical efficacy of simultaneous transurethral resection of both bladder cancer and the prostate: a systematic review and meta-analysis. Aging Male. 2020;23(5):1182–1193.
  • Kachanov M, Vetterlein MW, Soave A, et al. Oncologic impact of concomitant prostate cancer characteristics at the time of radical cystoprostatectomy for bladder cancer: a population-based analysis. Aging Male. 2022;25(1):54–61.
  • Matsui Y, Nishiyama H, Watanabe J, et al. The current status of perioperative chemotherapy for invasive bladder: a multiinstitutional retrospective study in Japan. Int J Clin Oncol. 2005;10(2):133–138.
  • Chester JD, Hall GD, Forster M, et al. Systemic chemotherapy for patients with bladder cancer-current controversies and future directions. Cancer Treat Rev. 2004;30(4):343–358.